Vibostolimab coformulated with pembrolizumab (vibo/pembro) for previously treated advanced mismatch repair-deficient (dMMR) endometrial cancer: Results from cohort B1 of the phase 2 KEYVIBE-005 study
JOURNAL OF CLINICAL ONCOLOGY, sa.16, 2024 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Özet
- Basım Tarihi: 2024
- Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır